TuHURA Biosciences, Inc.(HURA)

Biotechnology · Tampa, FL

$1.95+0.08 (+4.28%)

Delayed quote: Oct 6, 2026, 2:19 PM EDT

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T18:21:41.965Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:21:41.965Z.

Quote observation: 2026-10-06T18:19:46.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -31,100,731
Quote market capitalization: 124,180,875
Total debt · period ending 2026-06-30: 407,023
Cash · period ending 2026-06-30: 995,977

FMP input reference: 521b0ab3da901f2a49dafbbedcb3688a082548b97bbb2cd5efdb729e6989e7c5

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

HURA EBITDA Yield Metrics

EBITDA YIELD

N/A

HURA Competitors' EBITDA Yield

HURA

TuHURA Biosciences, Inc.

Current

Market Cap

$124.18M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BGM

BGM Group Ltd.

vs HURA

Market Cap

$122.94M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TNXP

Tonix Pharmaceuticals Holding Corp.

vs HURA

Market Cap

$124.47M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SEER

Seer, Inc.

vs HURA

Market Cap

$121.78M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ENGN

enGene Holdings Inc.

vs HURA

Market Cap

$120.92M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TNYA

Tenaya Therapeutics, Inc.

vs HURA

Market Cap

$120.22M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ENTX

Entera Bio Ltd.

vs HURA

Market Cap

$126.92M

EBITDA Yield

N/A

TTM Avg

27.23%

3Y Avg

27.23%

5Y Avg

27.23%

NRXP

NRx Pharmaceuticals, Inc.

vs HURA

Market Cap

$127.07M

EBITDA Yield

N/A

TTM Avg

0.18%

3Y Avg

0.16%

5Y Avg

0.16%

CBUS

Cibus, Inc.

vs HURA

Market Cap

$122.13M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SPRB

Spruce Biosciences, Inc.

vs HURA

Market Cap

$119.68M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
TuHURA Biosciences, Inc. (HURA)	$124.18M	N/A	N/A	N/A	N/A
BGM Group Ltd. (BGM)vs ›	$122.94M	N/A	N/A	N/A	N/A
Tonix Pharmaceuticals Holding Corp. (TNXP)vs ›	$124.47M	N/A	N/A	N/A	N/A
Seer, Inc. (SEER)vs ›	$121.78M	N/A	N/A	N/A	N/A
enGene Holdings Inc. (ENGN)vs ›	$120.92M	N/A	N/A	N/A	N/A
Tenaya Therapeutics, Inc. (TNYA)vs ›	$120.22M	N/A	N/A	N/A	N/A
Entera Bio Ltd. (ENTX)vs ›	$126.92M	N/A	27.23%	27.23%	27.23%
NRx Pharmaceuticals, Inc. (NRXP)vs ›	$127.07M	N/A	0.18%	0.16%	0.16%
Cibus, Inc. (CBUS)vs ›	$122.13M	N/A	N/A	N/A	N/A
Spruce Biosciences, Inc. (SPRB)vs ›	$119.68M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

HURA EBITDA Yield Metrics

HURA Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics